Efficacy of Saccharomyces boulardii as a probiotic in dogs with lincomycin induced diarrhoea

• Autorzy: Aktas M S , Borku M.K. , Ozkanlar Y.
• Języki publikacji: EN

Abstrakty

EN

Twenty-four dogs were divided into three equal groups. Lincomycin was administered intramuscularly to all groups. However, group II was given S. boulardii after lincomycin induced diarrhoea occurred, and in group III, lincomycin was administered together with S. boulardii. Lincomycin caused diarrhoea in groups I (in 7.8±1.6 d) and II (in 6.9±2 d), but it did not cause diarrhoea in group III. The durations of diarrhoea were significantly different (P<0.05) between group I (6.5±1.2 d) and group II (2.9±0.4 d). The total short chain fatty acid (TSCFA) level was significantly lower (P<0.001) compared with their baselines in groups I and II at the time of the diarrhoeas' onset and cessation. Additionally, there were differences between groups at the time of diarrhoea cessation and 1 week after the treatment (P<0.05). In conclusion, lincomycin decreased TSCFAs causing diarrhoea in the dogs when given alone, and S. boulardii was effective in treating lincomycin induced diarrhoea and to prevent the occurrence of diarrhoea when given together with lincomycin.

Słowa kluczowe

EN

lincomycin; Saccharomyces boulardii; veterinary medicine; therapy; antibiotic; dog; probiotic; short-chain fatty acid; diarrhea; animal disease

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2007
• Tom: 51
• Numer: 3
• Opis fizyczny: p.365-369,fig.,ref.

Twórcy

autor

Aktas M S

• College of Veterinary Medicine, Ataturk University, 25700, Erzurum, Turkey

autor

Borku M.K.

autor

Ozkanlar Y.

Bibliografia

• 1. Atherton D., Robbins S.: Probiotics, A European Perspective. In: Biotechnology in the feed Industry. Ed. T.P. Lyons. Alltech Technical Publication, Kentucky 1987, pp. 167-176.
• 2. Baverud V., Gustafsson A., Franklin A., Lindholm A., Gunnarsson A.: Clostridium difficile associated with acute colitis in mature horses treated with antibiotics. Eq Vet J 1997, 29, 279-284.
• 3. Beniwal R.S., Arena V.C., Thomas L., Narla S., Imperiale T.F., Chaudrey R.A., Ahmad U.A.: A randomized trial of yogurt for prevention of antibiotic-associated diarrhea. Dig Dis Sci 2003, 48, 2077-2082.
• 4. Berezin E.B.: Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents 2000, 16, 521-526.
• 5. Boddy V.A., Elmer W.G., Mcfarland V.L., Levy H.R.: Influence of antibiotics on the recovery and kinetics of Saccharomyces boulardii in rats. Pharm Res 1991, 8, 796-800.
• 6. Boon R.J., Beale A.S.: Studies with temocillin in the hamster model of antibiotic-associated colitis. Drugs 1985, 29, 57-63.
• 7. Burrows C.F.: Diseases of the colon, rectum, and anus in the dog and cat. In: Veterinary Gastroenterology. Anderson N.V (ed). Lea & Febiger, Philadelphia 1980, pp. 553-592.
• 8. Buts J.P., Bernasconi P., Craynest M.P.V., Maldague P., Meyer R.D.: Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatric Res 1986, 20, 192-196.
• 9. Buts J.P., De Keyser N., Kolanowski J., Sokol E., Van Hoof F.: Maturation of villus and crypt cell functions in rat small intestine: role of dietary polyamines. Dig Dis Sci 1993, 38, 1091-1098.
• 10. Buts J.P., Keyser N.D., Raedemaeker L.D.: Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines. Pediatric Res 1994, 36, 1-7.
• 11. Castagliuolo L., Papadimitra G., Juffer A., Kelley C.P., LaMont J.T., Pothoulakis C.: Saccharomyces boulardii secretes a protease which inhibits Clostridium difficile toxin A receptor binding and enterotoxicity. Gastroenterology 1993, 104, A678.
• 12. Crezucka, D., Rampal, P.: Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 2002, 4, 733-739.
• 13. Dawson, K.A.: The use of yeast culture in animals feeds: a scientific application of direct fed microbials and challenges of the future. In: Biotechnology in the Feed Industry, 9th Annual Symposium, Proc Alltech's 1993, pp. 169-171.
• 14. Dumankar A.: General side effects of antibiotics. In: Symposium of practical antibiotic usage. Istanbul, 1997, pp. 73-79.
• 15. Filho-Lima J.V.M., Vieira E.C., Nicoli J.R.: Antagonistic effect of Lactobacillus acidophilus, Saccharomyces boulardii and Escherichia coli combinations against experimental infections with Shigella flexineri and Salmonella enteritidis subsp. Typhimurium in gnotobiotic mice. J Appl Microbiol 2000, 88, 365-370.
• 16. Guilford W.G., Center S.A., Strombeck D.R., Williams D.A., Meyer D.J.: Integration of gastrointestinal functions. In: Strombeck's Small Animal Gastroenterology. 3. Ed, W.B. Saunders Company, Philadelphia, 1995, pp.16-17.
• 17. Gustafsson A., Lund-Tonnesen S., Berstad A., Midtvedt T., Norin E.: Faecal short-chain fatty acids in patients with antibiotic-associated diarrhea, before and after faecal enema treatment. Scand J Gastroenterol 1998, 33, 721-727.
• 18. Hines R.S., Dickerson S.: Pseudomembranous enteritis associated with ciprofloxacin and Clostridium difficile in a penguin (Eudyptes chrysolophus). J Zoo Wildlife Med 1993, 24, 553-556.
• 19. Hove H., Tvede M., Mortensen B.: Antibiotic-associated diarrhea, Clostridium difficile, and short-chain fatty acids. Scand J Gastroenterol 1996, 31, 688-693.
• 20. Hoverstad T., Carlstedt-Duke B., Lingaas E., Midtvedt T., Norin K.E., Saxerholt H., Steinbakk M.: Influence of ampicillin, clindamycin, and metronidazole on faecal excretion of short-chain fatty acids in healthy subjects. Scand J Gastroenterol 1986, 21, 621-626.
• 21. Hoverstad T., Fausa O., Bjorneklett A., Bohmer T.: Short- chain fatty acids in normal human faeces. Scand J Gastroenterol 1984, 19, 375-381.
• 22. Högenaur C., Hammer H.F., Krejs G.J., Reisinger E.C.: Mechanisms and management of antibiotic-associated diarrhea. Clin Infec Dis 1998, 27, 702-710.
• 23. Hurley B.W., Nyugen C.C.: The spectrum of pseudomembranous enterocolitis and antibiotic- associated diarrhea. Arch Intern Med 2002, 162, 2177- 2184.
• 24. Jabbar A., Wright R. A.: Gastroenteritis and antibiotic- associated diarrhea. Prim Care Clin Office Pract 2003, 30, 63-80.
• 25. Koneman E.W., Allen S.B., Janda W.M., Schreckenber P.C., Win W.C.: The Enterobacteriacae. In: Color Atlas and Textbook of Diagnostic Microbiology. 5 Ed, Lippincott, N.Y., 1997, pp. 171-252.
• 26. Marks S.L., Kather E.J.: Bacterial-associated diarrhea in the dog: a critical appraisal. Vet Clin Small Anim 2003, 33, 1029-1060.
• 27. Merrigan M., Sambol S., Johnson S., Gerding D.L.: Susceptibility of hamsters to human pathogenic Clostridium difficile strain B1 following clindamycin, ampicillin or ceftriaxone administration. Anaerob 2003, 9, 91-95.
• 28. Muller E.L., Pitt H.A., George W.L.: Prairie dog model for antimicrobial agent-induced Clostridium difficile diarrhea. Infect Immun 1987, 55, 198-200.
• 29. Noyan A.: Blood Physiology, Yasamda ve Hekimlikte Fizyoloji, Meteksan, 8. Ed. Anonim Co., Ankara 1993, pp. 659-771.
• 30. Orchard J.L., Fekety R., Smith, J.R.: Antibiotic-associated colitis due to Clostridium difficile in a Kodiak bear. Am J Vet Res 1983, 44, 1547-1548.
• 31. Pathoulakis C., Kelly C.P., Joshi M.A., Gao N., Okeane C.J., Castagliuolo L., Lamont J.T.: Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993, 104, 1108-1115.
• 32. Rao S.S.C., Edwards C.A., Austen C.J., Bruce C.: Impaired colonic fermentation of carbohydrate after ampicillin. Gastroenterology 1988, 94, 928-932.
• 33. Regh M.F., Lu Y.S.: Clostridium difficile in a rabbit following antibiotic therapy for pasteurellosis. J Am Vet Med Assoc 1981, 179, 1296-1297.
• 34. Riley T.V., Adams J.E., Oneill G.L., Bowman R.A.: Gastrointestinal carriage of Clostridium difficile in cats and dogs attending veterinary clinics. Epidemiol Infect 1991, 107, 659-665.
• 35. Rodriguez A.C.P., Cara D.C., Fretez S.H.G.G., Cunha F.Q., Vieira E.C., Nicoli J.R., Vieira L.Q.: Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 2000, 89, 404-414.
• 36. Rothman S.W.: Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis. Med Microbiol Immunol (Berl.) 1981, 169, 187-196.
• 37. Surawicz C.M., Elmer G.W., Speelman P., Mcfarland L.V., Chinn J., Belle G.V.: Prevention of antibiotic- associated diarrhoea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989, 96, 981-988.
• 38. Tsukahara T., Iwasaki Y., Nakayama K., Ushidi K.: Microscopic structure of the large intestinal mucosa in piglets during an antibiotic-associated diarrhea. Vet Med Sci 2003, 65, 301-306.
• 39. Twedt D.C.: Clostridium perfiringens-associated diarrhoea in dogs. In: Proc Am Col Vet Int Med Forum, Washington DC, 1993, pp. 121-125.
• 40. Weber A., Kroth P., Heil G.: Occurrence of Clostridium difficile in faeces of dogs and cats. J Vet Med Series (B), 1989, 36, 568-576.
• 41. Wisker E., Daniel M., Rave G., Feldheim W.: Short-chain fatty acids produced in vitro from fibre residues obtained from mixed diets containing different breads and in human faeces during the ingestion of the diets. Br J Nutr 2000, 84, 31-37.
• 42. Zaouche A., Loukil C., Lagausie P.D., Macry J., Fitoussi F., Bernasconi P., Bingen E., Cezard J.P.: Effects of oral Saccharomyces boulardii on bacterial overgrowth, translocation, and intestinal adaptation after small-bowel resection in rats. Scand J Gastroenterol 2000, 35, 160- 165.